Addus HomeCare Corporation (NASDAQ:ADUS) Receives Average Rating of “Moderate Buy” from Brokerages

by · The Markets Daily

Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, seven have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $133.2222.

A number of analysts recently commented on ADUS shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Stephens decreased their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Truist Financial set a $135.00 price objective on Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th.

Check Out Our Latest Stock Analysis on ADUS

Addus HomeCare Trading Down 0.8%

Shares of ADUS stock opened at $93.65 on Friday. The stock has a 50-day simple moving average of $105.19 and a 200 day simple moving average of $110.83. The stock has a market capitalization of $1.75 billion, a P/E ratio of 17.98, a P/E/G ratio of 1.31 and a beta of 0.92. Addus HomeCare has a fifty-two week low of $92.83 and a fifty-two week high of $124.43. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.11.

Insider Activity at Addus HomeCare

In other news, EVP Darby Anderson sold 396 shares of the company’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $41,722.56. Following the completion of the sale, the executive vice president directly owned 46,246 shares of the company’s stock, valued at $4,872,478.56. This represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP David W. Tucker sold 379 shares of the stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $39,931.44. Following the completion of the transaction, the executive vice president owned 10,423 shares of the company’s stock, valued at $1,098,167.28. This trade represents a 3.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 16,610 shares of company stock valued at $1,768,970 over the last ninety days. Company insiders own 4.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Global Retirement Partners LLC raised its holdings in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after acquiring an additional 186 shares during the period. Larson Financial Group LLC boosted its stake in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC purchased a new position in Addus HomeCare during the 4th quarter worth approximately $29,000. Private Trust Co. NA grew its position in Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares in the last quarter. Finally, Arax Advisory Partners raised its stake in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Recommended Stories